This is a preview of subscription content, log in via an institution to check access.
References
Ruffy R, Lal R, Kouchoukos N, Kim SS. Combined bipolar dual chamber pacing and automatic implantable cardioverter/defibrillator. J Am Coll Cardiol 1986;7: 933–937.
Calkins H, Brinker J, Veltri EP, Guarnieri T, Levine JH. Clinical interactions between pacemakers and automatic implantable cardioverter-defibrillators. J Am Coll Cardiol 1990;16:666–673.
Jung W, Lüderitz B. Implantation of an arrhythmia management system for ventricular and supraventricular tachyarrhythmias. Lancet 1997;349:853–854.
Cheitlin GG, Conill A, Epstein AE, et al. ACC/AHA guidelines for implantation of cardiac pacemakers and antiarrhythmia devices: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Pacemaker Implantation). J Am Coll Cardiol 1998;31:1175–1209.
Greenberg RM, Degeratu FT. Use of atrial and ventricular electrograms from a dual chamber implantable cardioverter defibrillator to elucidate a complex dysrhythmia. Pacing Clin Electrophysiol 1998;21:2002–2004.
Ovsyshcher IE, Hayes D, Furman S. Dual chamber pacing is superior to ventricular pacing. Fact or controversy? Circulation 1998;97:2368–2370.
The Antiarrhythmics Versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmicdrug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997;337:1576–1583.
Jung W, Wolpert C, Tenzer D, Spehl S, Schneider C, Bahman E, Kirchhoff PG, Lüderitz B. Incidence of spontaneous atrial tachyarrhythmias in patients treated with a combined atrioventricular defibrillator. Circulation 1998;98:190 (abstract).
Rosenqvist M, Beyer T, Block M, den Dulk K, Minten J, Lindemans F, on behalf of the European 7219 Jewel ICD Investigators. Adverse events with transvenous implantable cardioverter-defibrillators. A prospective multicenter study. Circulation 1998;98:663–670.
Korte T, Jung W, Wolpert C, Spehl S, Schumacher B, Esmailzadeh B, Lüderitz B. A new classification algorithm for discrimination of ventricular from supraventricular tachycardia in a dual chamber implantable cardioverter defibrillator. J Cardiovasc Electrophysiol 1998;9:70–73.
Maron BJ, Nishimura RA, McKenna WJ, Rakowski H, Josephson ME, Kieval RS, for the M-PATHY Study Investigators. Assessment of permanent dual-chamber pacing as a treatment for drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy. Circulation 1999;99:2927–2933.
Eldar M, Griffin JC, Van Hare GF, Witherell C, Bhandari A, Benditt D, Scheinman MM. Combined use of beta-adrenergic blocking agents and long-term cardiac pacing for patients with the long QT syndrome. J Am Coll Cardiol 1992;20:830–837.
Moss AJ, Hall WJ, Cannom DS, Daubert J, Higgins S, Klein H, Levine J, Saksena S, Waldo A, Wilber D, Brown M, Heo M on behalf of the Multicenter Automatic Defibrillator Implantation Trial Investigators. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmias. N Engl J Med 1996;335:1933–1940.
Higgins SL, Williams SK, Pak JP, Meyer DB. Indications for implantation of a dual-chamber pacemaker combined with an implantable cardioverter-defibrillator. Am J Cardiol 1998;81:1360–1362.
Best PJM, Hayes DL, Stanton MS. The potential usage of dual chamber pacing in patients with implantable cardioverter defibrillators. Pacing Clin Electrophysiol 1999;22:79–85.
Rights and permissions
About this article
Cite this article
Jung, W., Lüderitz, B. Should All Candidates for ICD Therapy Receive a Dual Chamber System?. J Interv Card Electrophysiol 3, 203–206 (1999). https://doi.org/10.1023/A:1009876514504
Issue Date:
DOI: https://doi.org/10.1023/A:1009876514504